According to Fortress Biotech 's latest financial reports the company's total liabilities are $0.16 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.24 B | 43.16% |
2021-12-31 | $0.17 B | 25.08% |
2020-12-31 | $0.13 B | -11.36% |
2019-12-31 | $0.15 B | 26.92% |
2018-12-31 | $0.12 B | -3.35% |
2017-12-31 | $0.12 B | 42.94% |
2016-12-31 | $87.76 M | 155.59% |
2015-12-31 | $34.33 M | 82.62% |
2014-12-31 | $18.8 M | -2.6% |
2013-12-31 | $19.3 M | 1.82% |
2012-12-31 | $18.95 M | 346.83% |
2011-12-31 | $4.24 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Veracyte VCYT | $70.8 M | -57.33% | ๐บ๐ธ USA |
Advaxis ADXS | $40.99 M | -75.29% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $0.37 B | 126.00% | ๐บ๐ธ USA |